We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+14.33%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$875B
AUM Growth
+$155B
Cap. Flow
-$3.12B
Cap. Flow %
-0.36%
Top 10 Hldgs %
24.48%
Holding
14,336
New
1,794
Increased
5,240
Reduced
5,148
Closed
2,105

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.35%
2 Technology 1.74%
3 Consumer Discretionary 0.9%
4 Financials 0.71%
5 Communication Services 0.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALTG icon
12276
Alta Equipment Group
ALTG
$204M
-45,844
Closed -$356K
ALTI icon
12277
AlTi Global
ALTI
$469M
-51,632
Closed -$214K
ALX
12278
Alexander's
ALX
$1.4B
-2,930
Closed -$660K
ALV icon
12279
Autoliv
ALV
$8.97B
-4,102
Closed -$491K
AMBP icon
12280
Ardagh Metal Packaging
AMBP
$3.07B
-175,552
Closed -$699K
AMBP icon
12281
PUT
Ardagh Metal Packaging
AMBP
$3.07B
-12,800
Closed -$54.8K
AMED
12282
CALL
DELISTED
Amedisys
AMED
-23,400
Closed -$2.3M
AMED
12283
PUT
DELISTED
Amedisys
AMED
-13,200
Closed -$1.3M
AMH icon
12284
CALL
American Homes 4 Rent
AMH
$12.1B
-10,000
Closed -$361K
AMLP icon
12285
Alerian MLP ETF
AMLP
$13.3B
-14,336
Closed -$693K
AMLX icon
12286
Amylyx Pharmaceuticals
AMLX
$4.04B
-110,846
Closed -$1.04M
AMN icon
12287
PUT
AMN Healthcare
AMN
$1.35B
-27,200
Closed -$562K
AMOM icon
12288
Qraft AI-Enhanced US Large Cap Momentum ETF
AMOM
$21.9M
-11,791
Closed -$540K
AMPGW
12289
DELISTED
Amplitech Group Warrants
AMPGW
-23,127
Closed -$10.4K
AMPH icon
12290
Amphastar Pharmaceuticals
AMPH
$931M
-54,598
Closed -$1.25M
AMPX.WS icon
12291
Amprius Technologies Warrants
AMPX.WS
$420M
-74,433
Closed -$38.7K
GOLD
12292
PUT
Gold.com Inc
GOLD
$1.33B
-21,100
Closed -$468K
AMRX icon
12293
PUT
Amneal Pharmaceuticals
AMRX
$6.16B
-37,400
Closed -$303K
AMX icon
12294
America Movil
AMX
$70B
-11,505
Closed -$219K
ANGH icon
12295
Anghami
ANGH
$32.1M
-1,450
Closed -$7.12K
ANIK icon
12296
Anika Therapeutics
ANIK
$282M
-15,735
Closed -$166K
ANGO icon
12297
AngioDynamics
ANGO
$653M
-95,826
Closed -$925K
ANSS
12298
CALL
DELISTED
Ansys
ANSS
-47,500
Closed -$16.7M
ANSS
12299
DELISTED
Ansys
ANSS
-27,107
Closed -$9.52M
ANSS
12300
PUT
DELISTED
Ansys
ANSS
-122,900
Closed -$43.2M

Similar funds

Jeff Yass's Q3 2025 Portfolio in Review

As of Q3 2025, Jeff Yass held 14,336 positions worth $875B, up 22% from $720B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass's Q3 2025 filing shows 1,794 new, 5,240 increased, 5,148 reduced and 2,105 closed positions. Its largest new stake was BitMine Immersion Technologies: 7,689,603 shares worth $399M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 94% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q3 2025 buy was BitMine Immersion Technologies: 7,689,603 shares worth $399M.
  • Jeff Yass added most to Meta Platforms (Facebook) in Q3 2025, an estimated $646M increase.
  • Jeff Yass's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
  • Jeff Yass fully exited iShares Core MSCI Total International Stock ETF in Q3 2025, selling an estimated $123M.
  • Jeff Yass's ten largest holdings make up 24% of its $875B portfolio in Q3 2025.
  • Jeff Yass opened 1,794 new positions and closed 2,105 in Q3 2025.
  • Jeff Yass's portfolio value rose 22% quarter-over-quarter to $875B.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.